ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2019 American Transplant Congress

    Renal Safety Of Entecavir And Tenofovir With Hepatitis B Immunoglobulin In Liver Transplant Patients

    D. Kim1, J. Lee1, E. Kim1, S. Kim1, K. Ihn1, D. Joo1, K. Huh1, B. Kim2, M. Kim1, S. Kim1, Y. Kim1, J. Lee1

    1Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of, 2Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

    *Purpose: Combination of potent nucleos(t)ide analougues (NAs) and hepatitis B immunoglobulin is recommended after liver transplantation for the prevention of hepatitis B virus (HBV) recurrence.…
  • 2019 American Transplant Congress

    Liver Transplantation for Acute Liver Failure: A 16 Year Experience with 214 Patients in the Post-MELD Era

    R. McMillan, T. Ito, A. Aziz, A. Amin, A. Murray, J. DiNorcia III, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

    Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA

    *Purpose: Liver transplantation (LT) remains the gold standard treatment for acute liver failure (ALF). Our center has previously reported outcomes in the pre-Model for End…
  • 2019 American Transplant Congress

    CD47 Blockade Promotes Hepatic Macrophage Polarization toward M1 during Normothermic Machine Perfusion of Discarded Human Livers

    M. Xu1, F. Zhou1, S. Garcia-Aroz1, B. Banan1, W. Yang2, G. Upadhya1, K. Byrnes3, B. Wong1, P. Manning4, Y. Lin1, W. Chapman1

    1Department of Surgery, Washington University School of Medicine, St. Louis, MO, 2Department of Genetics, Washington University School of Medicine, St. Louis, MO, 3Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 4Arch Oncology, St. Louis, MO, USA, St. Louis, MO

    *Purpose: M1 macrophages have been shown to be able to phagocytize dead cells after ischemia-reperfusion injury (IRI). This study investigated the therapeutic effect of CD47…
  • 2019 American Transplant Congress

    Outcomes Following Open Inguinal Hernia Repair in Liver Transplant versus Cirrhotic Patients

    N. Siegel, A. Kernodle, S. DiBrito, T. Ishaque, D. Segev, J. Garonzik-Wang

    Johns Hopkins, Baltimore, MD

    *Purpose: Patients with cirrhosis are at an increased risk for post-operative complications after open inguinal hernia repair (OIHR). Conversely, liver transplant recipients (LTR) may have…
  • 2019 American Transplant Congress

    Five Years after Right Hepatectomy for Living Liver Donation: Donor State of Health

    D. P. Hoyer, E. Malamutmann, G. Bagias, A. Oezcelik

    General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany

    *Purpose: Of utmost importance in living liver donation is the avoidance of postoperative complications and reduction of quality of life of the donor.*Methods: Inclusion criteria…
  • 2019 American Transplant Congress

    Use, Safety and Effectiveness of Hepatitis B Virus NAT-Positive Donor Livers in the Current Era

    T. C. Lee, K. Safdar, L. K. Winer, M. C. Morris, A. Kassam, K. Luckett, R. Quillin III, K. Bari, N. Anwar, S. A. Shah

    University of Cincinnati, Cincinnati, OH

    *Purpose: The use of hepatitis B (HBV) core antibody positive (HBcAb+) donor allografts in liver transplantation (OLT) has become accepted practice; however, given limited data…
  • 2019 American Transplant Congress

    When to Transplant for Wilson’s Disease: A Review

    M. Flanagan, S. Koohmaraie, M. Kueht, R. Cotton, C. O'Mahony, A. Rana, J. Goss, N. Galvan

    Baylor College of Medicine, Houston, TX

    *Purpose: Wilson’s disease (WD) is a rare genetic disorder of copper metabolism, which leads to the accumulation of copper in the body, causing damage to…
  • 2019 American Transplant Congress

    Ex Vivo Resection And Autologous Liver Transplantation As Management Concept For Extensive Malignancy

    K. Bruestle1, A. Griesemer2, S. Lobritto2, M. Martinez2, J. Vittorio2, D. Yamashiro2, E. Bacha3, T. Kato2

    1Columbia Center for Translational Immunology, Columbia University, New York City, NY, 2Columbia Center for Liver Disease and Transplantation, Columbia University Medical Center, New York City, NY, 3Morgan Stanley Children's Hospital, Columbia University Medical Center, New York City, NY

    *Purpose: Neuroblastomas are rare neural crest derived tumors which contribute disproportionally to childhood morbidity and mortality. Surgical resection remains standard treatment, however adequate resection is…
  • 2019 American Transplant Congress

    Clinical Presentation After Hepatitis B Recurrence In Liver Transplant Patients

    W. Lee, C. Cheng, T. Wu, Y. Wang, C. Lee, T. Wu, H. Chou, K. Chan

    Chang-Gung Hospital, Taoyuan, Taiwan

    *Purpose: Combination of anti-hepatitis B immunoglobulin and antiviral agents is the standard care for prophylaxis of hepatitis B virus (HBV) recurrence after liver transplantation. However,…
  • 2019 American Transplant Congress

    Lower Alcohol Taxes Are Associated with Increased Liver Transplant Listing

    N. T. Shen1, M. Raver1, N. Hutchison1, A. Jesudian1, J. Bray2, B. Schackman3, R. S. Brown1

    1Medicine; Division of Gastroenterology and Hepatology, New York Presbyterian Hospital - Weill Cornell, New York, NY, 2Economics, University of North Carolina at Greensboro, Greensboro, NC, Greensboro, NC, 3Healthcare Policy and Research, Weill Cornell Medicine, New York, NY

    *Purpose: Alcoholic liver disease (ALD) is a leading indication for liver transplantation worldwide with rising prevalence. Whether relationships exist between transplant listing for ALD and…
  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences